Post-approval studies (Phase 4)UnknownNCT04311957
What this trial is testing
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Who this might be right for
HIV-1-infectionAntiretroviral Therapy
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic 386